Furuse K - Search Results

1

[Phase I clinical study of 21-consecutive-day oral administration of etoposide].

Noda K, Fukuoka M, Komatsu H, Hayashihara K, Ariyoshi Y, Tanaka K, Nakajima H, Terashima Y, Nagao K, Furuse K, et al. Noda K, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1994 Aug;21(10):1633-9. Gan To Kagaku Ryoho. 1994. PMID: 8060139 Clinical Trial. Japanese.

2

[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].

Hatae M, Ariyoshi Y, Fukuoka M, Furuse K, Noda K, Hirabayashi K, Yakushiji M, Ogawa M, Takaku F. Hatae M, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 2005 Apr;32(4):489-96. Gan To Kagaku Ryoho. 2005. PMID: 15853215 Clinical Trial. Japanese.

3

[Phase I study on DMDC].

Gemma A, Kudoh S, Fukuoka M, Kurita Y, Hasegawa K, Harada M, Mori K, Ariyoshi Y, Kurihara M, Furuse K, Horikoshi N, Kanamaru R, Fukuyama E, Yoneda S, Furue H, Taguchi T, Ota K, Wakui A, Tsukagoshi S, Niitani H. Gemma A, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1996 Nov;23(13):1799-811. Gan To Kagaku Ryoho. 1996. PMID: 8937491 Clinical Trial. Japanese.

4

[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].

Fukuoka M, Noda K, Hasegawa K, Nakajima H, Furuse K, Hirabayashi K, Hasegawa K, Ogura T, Niitani H, Taguchi T. Fukuoka M, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1996 Nov;23(13):1813-24. Gan To Kagaku Ryoho. 1996. PMID: 8937492 Clinical Trial. Japanese.

5

[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)].

Fukuoka M, Negoro S, Kudo S, Furuse K, Nishikawa H, Takada Y, Kamei T, Niitani H, Taguchi T. Fukuoka M, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1996 Nov;23(13):1825-32. Gan To Kagaku Ryoho. 1996. PMID: 8937493 Clinical Trial. Japanese.

6

Phase I study of E7010.

Yamamoto K, Noda K, Yoshimura A, Fukuoka M, Furuse K, Niitani H. Yamamoto K, et al. Among authors: furuse k. Cancer Chemother Pharmacol. 1998;42(2):127-34. doi: 10.1007/s002800050795. Cancer Chemother Pharmacol. 1998. PMID: 9654112 Clinical Trial.

7

[Phase I study of raltitrexed (ZD-1694)].

Horikoshi N, Aiba K, Fukuoka M, Akazawa S, Sakata Y, Furuse K, Kanamaru R, Kudoh S, Konishi T, Kurihara M, Niitani H, Furue H, Tsukagoshi S, Taguchi T, Yoshida S, Ota K, Kotake T, Wakui A. Horikoshi N, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1998 Nov;25(13):2075-84. Gan To Kagaku Ryoho. 1998. PMID: 9838910 Clinical Trial. Japanese.

8

Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.

Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K. Tohda Y, et al. Among authors: furuse k. Chemotherapy. 1999 May-Jun;45(3):197-204. doi: 10.1159/000007183. Chemotherapy. 1999. PMID: 10224342

9

[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].

Furuse K, Fukuoka M, Kurita Y, Ariyoshi Y, Niitani H, Yoneda S, Fujii M, Hasegawa K, Nishiwaki Y, Tamura M, et al. Furuse K, et al. Gan To Kagaku Ryoho. 1992 Jun;19(6):879-84. Gan To Kagaku Ryoho. 1992. PMID: 1318698 Clinical Trial. Japanese.

10

[Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for lung cancer. rG.CSF Cooperation Study Group].

Ota K, Ariyoshi Y, Fukuoka M, Furuse K, Niitani H. Ota K, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1990 Jan;17(1):65-71. Gan To Kagaku Ryoho. 1990. PMID: 1688700 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters